Centre Hospitalier le Mans Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2015
NCT02595970
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier du Mans | Centre Hospitalier le Mans | Centre Hospitalier Le Mans, Intensive Care Unit | CENTRE HOSPITALIER LE MANS - LE MANS | CH Le Mans

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 4)

Emergencies (Phase 4)

Lacerations (Phase 4)

Pneumonia (Phase 3)

Psoriasis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 8